NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

AstraZeneca Pharma India today reported a net profit of Rs. 38.12 crore for the fourth quarter ended March 31, 2015. The company had posted a net loss of Rs. 2.56 lakh during the same period of the previous fiscal. Net sales stood at Rs. 120.80 crore during the quarter, while…

news

Bavarian Nordic is hot property after striking two big vaccine deals but the small Danish company is not for sale, despite a wave of consolidation in the healthcare industry, its chief told Reuters. Best known before for selling smallpox vaccine to governments worried about biosecurity, Bavarian's share price has tripled…

news

Swiss drugmaker Novartis is raising its bet on smart technology by collaborating with U.S. start-up Rani Therapeutics on a “robotic pill” for complex biotech drugs that would normally have to be given by injection. Rani said it would run feasibility studies over the next 18-24 months to evaluate how selected…

news

AbbVie, a global biopharmaceutical company, has completed the acquisition of Pharmacyclics, Inc. enhancing AbbVie's scientific and commercial presence in oncology. Pharmacyclics is a leader in the haematological oncology market with Imbruvica (ibrutinib), a first-in-class BTK-inhibitor used to treat haematological cancers, a $24 billion global market. "The companies' shared expertise, combined…

news

GlaxoSmithKline plc  has submitted a regulatory application to the Japanese Ministry of Health, Labour and Welfare (MHLW) for mepolizumab as an add-on maintenance treatment for patients with severe eosinophilic asthma who experience exacerbations on standard treatment. Mepolizumab is an anti IL-5 monoclonal antibody delivered in a 100mg fixed dose via…

news

Drug firm Lupin has submitted fresh studies to the European Medicines Agency (EMA) for two products, which are among 700 generic drugs suspended by the health regulator due to flawed clinical trial data provided by GVK Bio. "The company has successfully conducted the new bio equivalence (BE) studies for the…

news

Hainan Shuangcheng Pharmaceuticals Co Ltd Says Ningbo unit plans to invest 540.9 million yuan ($87.28 million) in research and production of injection products.   reuters.com

news

Amgen announced the termination of its co-development and commercialisation agreement with AstraZeneca for brodalumab, an investigational IL-17 receptor inhibitor in development for patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis. The announcement follows Amgen’s decision to concentrate on other portfolio priorities after observing suicidal ideation and behaviour events…

news

Nantong Jinghua Pharmaceutical Co Ltd Says plans to acquire investment and enterprise management company for 691.6 million yuan ($111.56 million)via cash and share issue.   reuters.com

news

Biopharmaceutical firm Suven Life Sciences today said it has been granted one patent each by Mexico and Singapore for a drug used in the treatment of neurodegenerative diseases. Neurodegenerative diseases include Alzheimer's, Schizophrenia and Parkinson's. In a BSE filing, the company said it has been granted "one product patent from…